TFBS Bioscience Inc.

TWO:6939 Taiwan Diagnostics & Research

Market Cap

$20.11 Million

NT$665.36 Million TWD

Market Cap Rank

#45927 Global

#2033 in Taiwan

Share Price

NT$19.00

Change (1 day)

-0.52%

52-Week Range

NT$18.85 - NT$21.10

All Time High

NT$21.10

TFBS Bioscience Inc. - Asset Resilience Ratio

Latest as of June 2025: 10.37%

TFBS Bioscience Inc. (6939) has an Asset Resilience Ratio of 10.37% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

NT$158.00 Million

Cash + Short-term Investments

Total Assets

NT$1.52 Billion

All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2022–2024)

This chart shows how TFBS Bioscience Inc.'s Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down TFBS Bioscience Inc.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	NT$0.00	0%
Short-term Investments	NT$158.00 Million	10.37%
Total Liquid Assets	NT$158.00 Million	10.37%

Asset Resilience Insights

Moderate Liquidity: TFBS Bioscience Inc. has 10.37% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.